MedTrace Logo

Clinical and Genetic Examination of Usher Syndrome Patients' Cohort in Europe

NCT01954953 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2015-02-04

No results posted yet for this study

Summary

This study aims to characterize Usher patients in order to correlate this data with genetic information.

Tasks:

* Standardization and improvement of Usher syndrome diagnosis: refine and elaborate special tests of visual and otological function in association with genotype that enable to determine the most significant markers for Usher disease progression and therapeutic effect.
* Perform genotype and phenotype correlations in Usher syndrome patients
* Develop and maintain database for phenotypically and genotypically well-characterized patient cohorts, suitable for future therapeutic trials

Conditions

  • Usher Syndrome

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts

    lead OTHER

Eligibility

Min Age
6 Months
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2016-01-31

Countries

  • France
  • Germany
  • Netherlands
  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01954953 on ClinicalTrials.gov